Asia Pacific Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type, By Scope, By End User, By Country and Growth Forecast, 2025

List of Tables

The Asia Pacific Monoclonal Antibodies In Veterinary Health Market would witness market growth of 19.3% CAGR during the forecast period (2025-2032).

The China market dominated the Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $213.2 million by 2032. The Japan market is registering a CAGR of 18.6% during (2025 - 2032). Additionally, The India market would showcase a CAGR of 20.1% during (2025 - 2032).

One of the most notable trends shaping the Asia-Pacific monoclonal antibodies (mAbs) market in veterinary health is the rapid adoption of biologics in the treatment of companion animals. With increasing urbanization and rising disposable incomes, pet ownership across countries such as China, Japan, India, and Australia has surged significantly. Pet owners are now more conscious of animal health and demand advanced medical solutions similar to human healthcare.

Monoclonal antibodies are gaining popularity because they provide targeted treatment with minimal side effects, especially for chronic conditions like osteoarthritis, allergic dermatitis, and autoimmune disorders. Veterinarians are increasingly incorporating mAbs into routine practice as these treatments offer improved efficacy and longer duration of action compared to traditional drugs. A second trend involves regulatory modernization across Asia-Pacific.

The veterinary monoclonal antibody (mAb) market in China is emerging as a high-potential segment within the broader animal healthcare landscape. With a rapidly growing pet population, especially in urban centers, the demand for advanced veterinary care has intensified. Pet owners in China are increasingly willing to invest in higher-value treatments, driven by emotional attachment and rising disposable incomes. This has laid a strong foundation for the adoption of biologics, including monoclonal antibodies, especially for companion animals.

Japan's veterinary monoclonal antibody market is among the most sophisticated in Asia, reflecting the country's broader emphasis on high-quality healthcare for both humans and animals. Pet ownership is widespread, and cultural norms place a strong emphasis on preventive care and long-term wellness. This aligns closely with the capabilities of monoclonal antibodies, which offer targeted, effective treatment with fewer side effects than traditional pharmaceuticals.

India's monoclonal antibodies market for veterinary applications is at a formative stage but shows significant long-term promise. The rise in pet ownership, particularly among the urban middle class, is reshaping the expectations around animal care. While the majority of veterinary attention has historically been focused on livestock, companion animal health is gaining momentum, creating new pathways for biologic interventions. Hence, the Asia-Pacific region shows rising potential, with growing pet ownership, increasing awareness, and emerging investments in veterinary biologics laying the groundwork for future expansion.

Based on Animal Type, the market is segmented into Dogs and Other Animal Type. Based on Scope, the market is segmented into Dermatology, Pain, and Other Scope. Based on End User, the market is segmented into Veterinary Hospitals and Other End User. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Zoetis, Inc.
Virbac
Merck KGaA
Elanco Animal Health, Inc.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Phibro Animal Health Corporation
Indian Immunologicals Ltd.

Asia Pacific Monoclonal Antibodies In Veterinary Health Market Report Segmentation

By Animal Type

Dogs
Other Animal Type

By Scope

Dermatology
Pain
Other Scope

By End User

Veterinary Hospitals
Other End User

By Country

China
Japan
India
South Korea
Australia
Malaysia
Rest of Asia Pacific

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Animal Type
- 1.4.2 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Scope
- 1.4.3 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by End User
- 1.4.4 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market

4.1 Research & Development (R&D)
4.2 Regulatory & Clinical Trials
4.3 Technology Transfer & Process Validation
4.4 Manufacturing
4.5 Packaging & Distribution
4.6 Marketing & Veterinary Engagement
4.7 Post-Market Surveillance & Pharmacovigilance
4.8 Customer Feedback & Support

Chapter 5. Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market

Chapter 6. Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type

6.1 Asia Pacific Dogs Market by Country
6.2 Asia Pacific Other Animal Type Market by Country

Chapter 7. Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope

7.1 Asia Pacific Dermatology Market by Country
7.2 Asia Pacific Pain Market by Country
7.3 Asia Pacific Other Scope Market by Country

Chapter 8. Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User

8.1 Asia Pacific Veterinary Hospitals Market by Country
8.2 Asia Pacific Other End User Market by Country

Chapter 9. Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country

9.1 China Monoclonal Antibodies In Veterinary Health Market
- 9.1.1 China Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.1.2 China Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.1.3 China Monoclonal Antibodies In Veterinary Health Market by End User
9.2 Japan Monoclonal Antibodies In Veterinary Health Market
- 9.2.1 Japan Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.2.2 Japan Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.2.3 Japan Monoclonal Antibodies In Veterinary Health Market by End User
9.3 India Monoclonal Antibodies In Veterinary Health Market
- 9.3.1 India Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.3.2 India Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.3.3 India Monoclonal Antibodies In Veterinary Health Market by End User
9.4 South Korea Monoclonal Antibodies In Veterinary Health Market
- 9.4.1 South Korea Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.4.2 South Korea Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.4.3 South Korea Monoclonal Antibodies In Veterinary Health Market by End User
9.5 Australia Monoclonal Antibodies In Veterinary Health Market
- 9.5.1 Australia Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.5.2 Australia Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.5.3 Australia Monoclonal Antibodies In Veterinary Health Market by End User
9.6 Malaysia Monoclonal Antibodies In Veterinary Health Market
- 9.6.1 Malaysia Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.6.2 Malaysia Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.6.3 Malaysia Monoclonal Antibodies In Veterinary Health Market by End User
9.7 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market
- 9.7.1 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type
- 9.7.2 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope
- 9.7.3 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User

Chapter 10. Company Profiles

10.1 Zoetis, Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 Recent strategies and developments:
  - 10.1.5.1 Product Launches and Product Expansions:
- 10.1.6 SWOT Analysis
10.2 Virbac
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Regional Analysis
- 10.2.4 Recent strategies and developments:
  - 10.2.4.1 Partnerships, Collaborations, and Agreements:
- 10.2.5 SWOT Analysis
10.3 Merck KGaA
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 SWOT Analysis
10.4 Elanco Animal Health, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 SWOT Analysis
10.5 Boehringer Ingelheim International GmbH
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 SWOT Analysis
10.6 Ceva Sante Animale
- 10.6.1 Company Overview
- 10.6.2 SWOT Analysis
10.7 Phibro Animal Health Corporation
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expenses
10.8 Indian Immunologicals Ltd.
- 10.8.1 Company Overview

LIST OF TABLES

TABLE 1 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 2 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 3 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
TABLE 4 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 5 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 6 Asia Pacific Dogs Market by Country, 2021 - 2024, USD Million
TABLE 7 Asia Pacific Dogs Market by Country, 2025 - 2032, USD Million
TABLE 8 Asia Pacific Other Animal Type Market by Country, 2021 - 2024, USD Million
TABLE 9 Asia Pacific Other Animal Type Market by Country, 2025 - 2032, USD Million
TABLE 10 Use Case 1: Canine Monoclonal Antibody Therapies - Targeted Treatment Innovations for Dogs
TABLE 11 Use Case 2: Monoclonal Antibodies for Livestock & Exotic Animals - Immune-Driven Disease Control
TABLE 12 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 13 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 14 Asia Pacific Dermatology Market by Country, 2021 - 2024, USD Million
TABLE 15 Asia Pacific Dermatology Market by Country, 2025 - 2032, USD Million
TABLE 16 Asia Pacific Pain Market by Country, 2021 - 2024, USD Million
TABLE 17 Asia Pacific Pain Market by Country, 2025 - 2032, USD Million
TABLE 18 Asia Pacific Other Scope Market by Country, 2021 - 2024, USD Million
TABLE 19 Asia Pacific Other Scope Market by Country, 2025 - 2032, USD Million
TABLE 20 Use Case 1: Targeted Monoclonal Antibody Therapy for Canine Dermatological Conditions
TABLE 21 Use Case 2: Monoclonal Antibody-Based Pain Management in Veterinary Orthopedic Care
TABLE 22 Use Case 3: Monoclonal Antibodies for Veterinary Oncology, Immune Modulation & Infectious Disease
TABLE 23 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 24 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 25 Asia Pacific Veterinary Hospitals Market by Country, 2021 - 2024, USD Million
TABLE 26 Asia Pacific Veterinary Hospitals Market by Country, 2025 - 2032, USD Million
TABLE 27 Asia Pacific Other End User Market by Country, 2021 - 2024, USD Million
TABLE 28 Asia Pacific Other End User Market by Country, 2025 - 2032, USD Million
TABLE 29 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2024, USD Million
TABLE 30 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country, 2025 - 2032, USD Million
TABLE 31 China Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 32 China Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 33 China Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 34 China Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 35 China Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 36 China Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 37 China Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 38 China Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 39 Japan Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 40 Japan Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 41 Japan Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 42 Japan Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 43 Japan Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 44 Japan Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 45 Japan Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 46 Japan Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 47 India Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 48 India Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 49 India Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 50 India Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 51 India Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 52 India Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 53 India Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 54 India Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 55 South Korea Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 56 South Korea Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 57 South Korea Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 58 South Korea Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 59 South Korea Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 60 South Korea Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 61 South Korea Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 62 South Korea Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 63 Australia Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 64 Australia Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 65 Australia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 66 Australia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 67 Australia Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 68 Australia Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 69 Australia Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 70 Australia Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 71 Malaysia Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 72 Malaysia Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 73 Malaysia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 74 Malaysia Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 75 Malaysia Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 76 Malaysia Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 77 Malaysia Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 78 Malaysia Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 79 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2021 - 2024, USD Million
TABLE 80 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2025 - 2032, USD Million
TABLE 81 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2024, USD Million
TABLE 82 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2025 - 2032, USD Million
TABLE 83 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2024, USD Million
TABLE 84 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope, 2025 - 2032, USD Million
TABLE 85 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2024, USD Million
TABLE 86 Rest of Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User, 2025 - 2032, USD Million
TABLE 87 Key Information - Zoetis, Inc.
TABLE 88 Key Information - Virbac
TABLE 89 key Information - Merck KGaA
TABLE 90 Key information - Elanco Animal Health, Inc.
TABLE 91 Key Information - Boehringer Ingelheim International GmbH
TABLE 92 Key Information - Ceva SantE Animale
TABLE 93 Key Information - Phibro Animal Health Corporation
TABLE 94 Key Information - Indian Immunologicals Ltd

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 Asia Pacific Monoclonal Antibodies In Veterinary Health Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Monoclonal Antibodies In Veterinary Health Market
FIG 4 Porter's Five Forces Analysis - Monoclonal Antibodies In Veterinary Health Market
FIG 5 Value Chain Analysis of Monoclonal Antibodies In Veterinary Health Market
FIG 6 Key Costumer Criteria - Monoclonal Antibodies In Veterinary Health Market
FIG 7 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2024
FIG 8 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by Animal Type, 2032
FIG 9 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Animal Type, 2021 - 2032, USD Million
FIG 10 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by Scope, 2024
FIG 11 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by Scope, 2032
FIG 12 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Scope, 2021 - 2032, USD Million
FIG 13 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by End User, 2024
FIG 14 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by End User, 2032
FIG 15 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by End User, 2021 - 2032, USD Million
FIG 16 Asia Pacific Monoclonal Antibodies In Veterinary Health Market share by Country, 2024
FIG 17 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country, 2032
FIG 18 Asia Pacific Monoclonal Antibodies In Veterinary Health Market by Country, 2021 - 2032, USD Million
FIG 19 Swot Analysis: ZOETIS, INC.
FIG 20 SWOT Analysis: Virbac
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Elanco Animal Health, Inc.
FIG 23 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 24 SWOT Analysis: Ceva Sante Animale

Asia Pacific Monoclonal Antibodies In Veterinary Health Market Size, Share & Industry Analysis Report By Animal Type, By Scope, By End User, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents